Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. EGFR inhibitors as first-line therapy in advanced non-small cell lung cancer
Your Article Summary
See Latest ArticlesAngiostatic versus angiogenic chemokines in IPF and EAA
Respiratory Medicine, 10/08/09
Martina S et al. – Both IL–8 and ENA–78 probably play a different role in IPF and chronic EAA pathogenesis. While the authors suggest ENA–78 as the marker of at least partial reversibility of the lung impairment in the EAA patients, IL–8 could be rather an indicator of continuous exposition to provoking agent in EAA patients. IL–8 might serve as a potential marker of early phase of IPF.
Today in Restrictive Lung Dz...keeping you current
Receive free subspecialty "5-minute updates" via email
Lung involvement in patients with primary Sjögrens syndrome: What are the predictors?
Rheumatology International, 10/26/09
Effects of pulmonary rehabilitation in patients with restrictive lung diseases
Chest, 10/29/09
Pleural effusion from a candy wrapper
Cleveland Clinic Journal of Medicine, 11/04/09
Sponsor
Article Search
Sponsor